Evaluation of Covid 19 Anxiety in Endometriosis Patients

Covid19 Clinical Trial

Official title:

Endometriosis Patients Covid 19 Anxiety

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04337346
• Other study ID #: endocovid19
• Status: Completed
• Start date: April 5, 2020
• Est. completion date: April 25, 2020

Study information

• Verified date: May 2020
• Source: Kanuni Sultan Suleyman Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

It is aimed to measure the general anxiety and lifestyle information of endometriosis patients about covid 19 pandemic, to evaluate anxiety levels in this period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: April 25, 2020
• Est. primary completion date: April 20, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• endometriosis patients

• no psychiatric illness

• no antidepressant use

Exclusion Criteria:

• women who had not endometriosis

• no extra health conditions

• women younger than 18 and older than 45

Related Conditions & MeSH terms

• Covid19
• Endometriosis

Locations

Country	Name	City	State
Turkey	Pinar Yalcin Bahat	Istanbul	I?stanbul

Sponsors (1)

Lead Sponsor	Collaborator
Kanuni Sultan Suleyman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Covid 19 Anxiety levels in Endometriosis Patients	The Beck Anxiety Inventory (BAI); it measures the frequency of anxiety symptoms experienced by the patient. It consists of 21 questions in total. Each item gets an increasing score between 0-3. The total score ranges from 0 - 63. The following guidelines are recommended for the interpretation of scores: 0 -9, normal or no anxiety; 10 -18, mild to moderate anxiety; 19 -29, moderate to severe anxiety; and 30 - 63, severe anxiety.	20 days